Current position:Home >Product >
Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-(861392-99-6)
- Name: Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
- Synonyms:QTDONOXURZFSIG-UHFFFAOYSA-N;BenzeneacetaMide, 4-chloro-N-[1-[[(cyanoaMino)[(2-Methyl-3-pyridinyl)iMino]Methyl]aMino]-2,2-diMethylpropyl]-
- Molecular Formula:C21H25ClN6O
- Molecular Weight:412.9158
- CAS Registry Number:861392-99-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.861392-99-6 Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 1245527-15-4/1H-Pyrrolo[2,3-c]pyridine-2-ethanol, α-[2-[2-methoxy-5-(5-pyrimidinyl)phenyl]-2-methylpropyl]-α-(trifluoromethyl)-, (αR)-
- 1245526-82-2/Glucocorticoid receptor agonist
- 869725-27-9/Methanone, (4,6-dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoromethyl)-1H-inden-1-yl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]-, hydrochloride (1:2)
- 1021298-13-4/Methanone, [4-methyl-3-(1-pyrrolidinylsulfonyl)phenyl](octahydro-2(1H)-isoquinolinyl)-
- 887289-02-3/Benzamide, N-[2-(cyclopropylmethyl)-5-(1,1-dimethylethyl)-1,2-dihydro-1-methyl-3H-pyrazol-3-ylidene]-2-fluoro-3-(trifluoromethyl)-
- 452296-83-2/BMS 043
- 668455-62-7/Butanoic acid, 2-[3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-, (2R)-
- 1173435-64-7/BMS 665053
- 919482-16-9/2H-Benzimidazol-2-one, 1-[(2R)-2,3-dihydroxypropyl]-1,3-dihydro-3-[1-[(1R,3S,4S)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]-4-piperidinyl]-, hydrochloride (1:1)
- 919482-44-3/2H-Benzimidazol-2-one, 1-[(2R)-2,3-dihydroxypropyl]-1,3-dihydro-3-[1-[(1R,3S,4S)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]-4-piperidinyl]-
- 748136-54-1/OSIP 339391
- 917987-68-9/[3H]PSB-298
- 1029401-88-4/1H-Pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione, 6-[4-[2-[4-(5-chloro-2-benzothiazolyl)-1-piperazinyl]-1,1-dimethyl-2-oxoethoxy]phenyl]-1,3-dimethyl-
- 905311-24-2/PSB 601
- 46155-90-2/1H-Purine-2,6-dione, 3,4,5,9-tetrahydro-1,3-dimethyl-
- 1057677-92-5/2-(6-(4-(4-benzylphthalazin-1-yl)piperazin-1-yl)pyridin-3-yl)propan-2-ol
- 720690-73-3/GSK 189254A
- 1158838-43-7/Aurora A inhibitor II
- 861392-99-6/Benzeneacetamide, 4-chloro-N-[1-[[(cyanoamino)[(2-methyl-3-pyridinyl)imino]methyl]amino]-2,2-dimethylpropyl]-
- 1067647-43-1/1H-Indole-2,4-dione, 3-[2,5-dihydro-3-methyl-5-oxo-1-[4-(trifluoromethoxy)phenyl]-1H-pyrazol-4-yl]-3,5,6,7-tetrahydro-6,6-dimethyl-1-phenyl-3-(trifluoromethyl)-
- 145148-39-6/3-PiperidinaMine, N-[(2-Methoxyphenyl)Methyl]-2-phenyl-, (Hydrochloride) (1:2), (2S,3S)-
- 909106-60-1/A 876828
- 909106-97-4/A 924825
- 914088-64-5/Cazpaullone
- 700874-71-1/LY2109761
- 1025720-94-8/N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
- 1003883-60-0/1,2-Pyrrolidinedicarboxamide, N1-(4-chlorophenyl)-N2-[(4-chlorophenyl)methyl]-N2-(2-hydroxyethyl)-, (2R)-
- 1003882-41-4/1,2-Pyrrolidinedicarboxamide, N2-[(4-chlorophenyl)methyl]-N2-methyl-N1-[4-(trifluoromethyl)phenyl]-, (2R)-
- 212790-31-3/CP 481715
- 864947-20-6/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[1-(cyclopropylmethyl)-2,3-dioxo-3-(2-propen-1-ylamino)propyl]-3-[(2S)-2-[[[[(1S)-1-[(4,4-dimethyl-2,6-dioxo-1-piperidinyl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-